Female Sexual Dysfunction Support Protocol

Female sexual dysfunction (FSD) encompasses a range of issues including low sexual desire (hypoactive sexual desire disorder - HSDD), difficulty with arousal, problems achieving orgasm, and pain during sex. These issues affect up to 40% of women at some point and can significantly impact quality of life and relationships. Causes are often multifactorial, including hormonal changes (especially during menopause), psychological factors (stress, anxiety, depression, relationship issues), medications (especially antidepressants), and medical conditions.

IMPORTANT: Sexual dysfunction has many causes including relationship issues, stress, depression, hormonal changes, and medical conditions. A thorough evaluation by a healthcare provider is important. These supplements may help but don't address underlying psychological or relationship factors that may need counseling or therapy.

•Tribulus Terrestris is one of the most promising herbs for female sexual dysfunction. Studies show it can improve sexual desire, arousal, lubrication, and satisfaction. It may work by gently increasing androgen levels or improving androgen receptor sensitivity—androgens are important for female sexual desire too.

•Maca is a Peruvian adaptogenic root that has been used traditionally for enhancing sexuality. Research shows it can improve sexual desire in women, including those experiencing antidepressant-induced sexual dysfunction. Importantly, maca doesn't appear to work through hormone changes, suggesting other mechanisms.

•Fenugreek contains furostanol saponins that may support healthy hormone levels. Studies in women show improvements in sexual desire, arousal, and overall sexual function.

•DHEA is a hormone precursor that naturally declines with age. In women with low androgen levels (common after menopause or adrenal issues), DHEA supplementation can improve sexual desire and function. Intravaginal DHEA is also FDA-approved for treating vaginal atrophy.

•Ashwagandha is an adaptogenic herb that reduces stress and cortisol levels. Since stress is a major factor in female sexual dysfunction, addressing stress through adaptogens may help restore normal desire and function.

•Saffron has shown benefit in clinical trials for both general sexual dysfunction and antidepressant-induced sexual problems. It may work through serotonin modulation and anti-depressant effects.

•Ginkgo Biloba improves blood flow throughout the body including the genital area. It has some evidence for helping with antidepressant-induced sexual dysfunction.

•L-Arginine increases nitric oxide, which dilates blood vessels and can improve genital engorgement and arousal.

•Red Clover contains phytoestrogens that may help with menopausal sexual symptoms.

•Vitamin D deficiency is associated with sexual dysfunction, and many women are deficient. Maintaining adequate levels may support overall sexual health.

Expected timeline: Herbal adaptogens (maca, ashwagandha): 4-8 weeks for full effects. Tribulus and fenugreek: 4-8 weeks. DHEA: 4-12 weeks. L-arginine and ginkgo (blood flow): 2-4 weeks. Consistent use is important for these supplements.

Clinical Perspective

Female sexual dysfunction (FSD) encompasses desire disorders (HSDD—most common), arousal disorders, orgasmic disorders, and sexual pain disorders (dyspareunia, vaginismus). DSM-5 categories: female sexual interest/arousal disorder, female orgasmic disorder, genito-pelvic pain/penetration disorder. Prevalence: 40-50% report concerns; 12% report distressing dysfunction. Etiology: biological (hormonal—estrogen/androgen, vascular, neurological, medications), psychological (depression, anxiety, body image, trauma), sociocultural, relational. Risk factors: age, menopause, antidepressants (especially SSRIs), chronic illness, relationship factors.

CRITICAL: Evaluate underlying causes—depression, relationship issues, hormonal changes, medications (especially SSRIs/SNRIs), medical conditions, history of trauma. Comprehensive approach includes: psychoeducation, couples therapy, cognitive-behavioral therapy, pelvic floor physical therapy if relevant, addressing hormonal deficiencies. FDA-approved medications: flibanserin (Addyi) for premenopausal HSDD, bremelanotide (Vyleesi) for premenopausal HSDD, ospemifene for dyspareunia, vaginal DHEA (Intrarosa) for vulvovaginal atrophy.

•Tribulus Terrestris (B-grade): Steroidal saponins (protodioscin); may increase androgen activity. Clinical trial: improved desire, arousal, lubrication, orgasm in postmenopausal women (PMID: 25963020). Systematic review: evidence supports efficacy for female HSDD (PMID: 29314632). 250-750mg daily standardized to 40-45% saponins. Monitor androgens with long-term use.

•Maca (Lepidium meyenii) (B-grade): Adaptogenic; mechanism not fully clear—doesn't significantly alter hormone levels but may affect receptor sensitivity or neurotransmitter balance. RCT: improved SSRI-induced sexual dysfunction in women (PMID: 19781622). Systematic review: evidence for improving sexual desire (PMID: 20090350). 1.5-3g daily. Well-tolerated.

•Fenugreek (B-grade): Furostanol saponins may modulate hormone levels. Clinical trial in women: improved sexual desire, arousal (PMID: 25914334). 300-600mg standardized extract daily. May affect blood sugar; generally well-tolerated.

•DHEA (B-grade): Androgen precursor; declines with age. Converts to testosterone and estrogen. Systematic review: DHEA improves sexual function in women with adrenal insufficiency and postmenopausal women (PMID: 24565856). Meta-analysis: intravaginal DHEA effective for vulvovaginal atrophy and associated dyspareunia (PMID: 26754152). Oral: 10-25mg daily; intravaginal: prescription (Intrarosa). Monitor hormone levels. May cause acne, hirsutism at higher doses.

•Ashwagandha (B-grade): Adaptogen; reduces cortisol, may improve DHEA levels. Pilot study: improved Female Sexual Function Index (FSFI) scores (PMID: 25554739). 300-600mg daily KSM-66 or Sensoril extract. Addresses stress component.

•Saffron (B-grade): Crocin, safranal have antidepressant, serotonergic effects. RCT: improved arousal and lubrication in women with fluoxetine-induced sexual dysfunction (PMID: 22552758). 30mg daily. Generally safe.

•Ginkgo Biloba (C-grade): Improves peripheral circulation; antioxidant. Pilot study showed benefit for antidepressant-induced dysfunction (PMID: 9611693). Review: mixed evidence (PMID: 21094195). 120-240mg standardized extract daily. May increase bleeding risk.

•L-Arginine (C-grade): Nitric oxide precursor; increases genital blood flow. RCT with yohimbine: improved sexual function in women (PMID: 12851125). 2.5-5g daily. May lower blood pressure; avoid with PDE5 inhibitors.

•Red Clover (C-grade): Isoflavones (genistein, daidzein) have weak estrogenic effects. Review: may help menopausal symptoms including sexual function (PMID: 18715514). 40-80mg isoflavones daily. Consider hormone-dependent cancer history.

•Vitamin D (C-grade): VDR in ovarian tissue, vaginal epithelium. Deficiency associated with sexual dysfunction. Review: maintaining adequate levels may support sexual function (PMID: 28646635). Target 30-50 ng/mL. 2000-4000 IU daily.

Biomarker targets: FSFI (Female Sexual Function Index) scores, hormone levels if indicated (estradiol, testosterone, DHEA-S, prolactin, TSH), relationship satisfaction, mood measures (PHQ-9 for depression).

Protocol notes: Comprehensive approach is key—supplements alone often insufficient. Address relationship factors; couples therapy can be highly effective. Cognitive-behavioral therapy, mindfulness-based approaches have evidence. Screen for depression, anxiety. Review medications—SSRIs/SNRIs commonly cause dysfunction; consider bupropion switch or augmentation. Pelvic floor PT for pain disorders, vaginismus. Vaginal lubricants and moisturizers for dryness/atrophy. Local estrogen highly effective for vulvovaginal atrophy (minimal systemic absorption). Bremelanotide and flibanserin FDA-approved for premenopausal HSDD if other approaches fail. Testosterone (off-label) used by some specialists for refractory cases. Exercise improves blood flow and body image. Sleep optimization—fatigue is major libido killer. Address chronic pain conditions. Mindfulness practice can improve arousal. Communication with partner about needs and preferences.

View All Protocols